Clinical Dilemmas in Inflammatory Bowel Disease.

By: Irving, PeterContributor(s): Rampton, David | Shanahan, FergusMaterial type: TextTextPublisher: Chichester : John Wiley & Sons, Incorporated, 2006Copyright date: ©2008Edition: 1st edDescription: 1 online resource (264 pages)Content type: text Media type: computer Carrier type: online resourceISBN: 9780470750285Subject(s): Inflammatory bowel diseases -- Decision making | Inflammatory bowel diseasesGenre/Form: Electronic books.Additional physical formats: Print version:: Clinical Dilemmas in Inflammatory Bowel DiseaseDDC classification: 616.344 LOC classification: RC862.I53C553 2006Online resources: Click to View
Contents:
Intro -- Clinical Dilemmas in: Inflammatory Bowel Disease -- Contents -- List of Contributors -- Preface -- Part 1 Investigating IBD in the 21st Century -- 1 Capsule endoscopy: do we need it? -- 2 Pathology reports - pitfalls for the unwary -- 3 Non-invasive diagnosis and assessment -- 4 What is the best way to image perianal Crohn's disease? -- 5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome -- 6 Abnormal liver tests - what should we do about them? -- Part 2 Medical Treatment: Making the Most of What We've Got - 5-ASA drugs -- 5-ASA drugs -- 7 Is monitoring necessary? -- 8 Do they have a role in Crohn's disease? -- Steroids -- 9 Steroids in Crohn's: are they obsolete? -- Antibiotics for Crohn's disease -- 10 Antibiotics: which, when, and for how long? -- 11 M ycobacterium av ium paratuberculosis in Crohn's disease: player or spectator? -- Immunomodulators -- 12 TPMT testing: is it essential? -- 13 6-Mercaptopurine or azathioprine? -- 14 Thiopurines: how long should we use them for? -- 15 Making the most of methotrexate -- 16 Cyclosporine: balancing risk and benefit -- Infliximab -- 17 Contraindications - absolute or relative? -- 18 How can we prevent tuberculosis? -- 19 Dealing with infusion reactions -- 20 Use in ulcerative colitis -- 21 Infliximab and surgery: health or hazard? -- Nutritional therapy for Crohn's disease -- 22 Nutritional therapy for Crohn's disease: is it for adults? -- Part 3 Medical Treatment: What's Round the Corner? -- 23 Trials and tribulations - interpreting clinical trials in IBD -- 24 Genetics - clinical and therapeutic applications -- 25 Probiotics - separating science from snakeoil -- 26 Worms -- 27 Smoking and nicotine - poison for Crohn's, potion for colitis? -- 28 Heparin -- 29 Leukocytapheresis: filtering out the facts -- 30 Appendectomy for ulcerative colitis - a therapeutic option?.
31 Biologic treatments in IBD -- 32 Stem cell transplantation for IBD -- 33 Complementary and alternative therapy - the way forward or a step back? -- Part 4 Common Clinical Challenges: Beyond the Text Book -- 34 Functional problems -- 35 Psychological stress: something to worry about? -- 36 Drugs to avoid -- 37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD? -- 38 Iron replacement - is it safe and effective? -- 39 Hepatitis B and C viruses - how do they affect management of IBD? -- 40 Pregnancy: what drugs can we use? -- 41 How to prevent growth failure in children -- 42 Predicting outcome in severe UC -- 43 Refractory proctitis -- 44 CMV co-infection - does it matter? -- 45 Treatment of oral Crohn's disease -- 46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease -- 47 Short bowel -- 48 Management of internal fistulae -- 49 What is indeterminate colitis? -- 50 Pouches for indeterminate colitis? -- 51 Colitis-associated cancer: what's the risk to your patients? -- 52 What to do with dysplasia, DALMs, and adenomas -- Part 5 Managing IBD Outside the Gut -- 53 Pyoderma gangrenosum -- 54 Arthritides - helping the joints without harming the gut -- 55 Prevention and treatment of osteoporosis -- 56 Sclerosing cholangitis - what to do? -- 57 Thromboembolic disease: an under-recognized complication? -- 58 Pulmonary manifestations: rare but real -- Part 6 Are You Sure it's IBD? -- 59 Intestinal infections: mimics and precipitants of relapse -- 60 Microscopic colitis -- 61 Diverticular colitis -- Part 7 The IBD Service: Time for a Rethink? -- 62 Outpatient services - do doctors still have a role? -- 63 Shared care: tactical team selection -- 64 Databases - are they worth the bother? -- Index.
Summary: Evidence-based guidance to answer more than 60 controversial clinical questions on inflammatory bowel disease Clinical Dilemmas in Inflammatory Bowel Disease is a practical handbook providing quick but detailed answers to the questions and challenges that you are faced with daily in the clinical setting. Each short chapter addresses a different topic and provides evidence-based guidance on subjects ranging from optimising current management through to special management problems and novel treatments. This book is suitable for all medical professionals involved in the care of patients with IBD: established and trainee gastroenterologists, colorectal surgeons, pathologists, radiologists, specialist nurses, pharmacists, dieticians and counsellors.
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
No physical items for this record

Intro -- Clinical Dilemmas in: Inflammatory Bowel Disease -- Contents -- List of Contributors -- Preface -- Part 1 Investigating IBD in the 21st Century -- 1 Capsule endoscopy: do we need it? -- 2 Pathology reports - pitfalls for the unwary -- 3 Non-invasive diagnosis and assessment -- 4 What is the best way to image perianal Crohn's disease? -- 5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome -- 6 Abnormal liver tests - what should we do about them? -- Part 2 Medical Treatment: Making the Most of What We've Got - 5-ASA drugs -- 5-ASA drugs -- 7 Is monitoring necessary? -- 8 Do they have a role in Crohn's disease? -- Steroids -- 9 Steroids in Crohn's: are they obsolete? -- Antibiotics for Crohn's disease -- 10 Antibiotics: which, when, and for how long? -- 11 M ycobacterium av ium paratuberculosis in Crohn's disease: player or spectator? -- Immunomodulators -- 12 TPMT testing: is it essential? -- 13 6-Mercaptopurine or azathioprine? -- 14 Thiopurines: how long should we use them for? -- 15 Making the most of methotrexate -- 16 Cyclosporine: balancing risk and benefit -- Infliximab -- 17 Contraindications - absolute or relative? -- 18 How can we prevent tuberculosis? -- 19 Dealing with infusion reactions -- 20 Use in ulcerative colitis -- 21 Infliximab and surgery: health or hazard? -- Nutritional therapy for Crohn's disease -- 22 Nutritional therapy for Crohn's disease: is it for adults? -- Part 3 Medical Treatment: What's Round the Corner? -- 23 Trials and tribulations - interpreting clinical trials in IBD -- 24 Genetics - clinical and therapeutic applications -- 25 Probiotics - separating science from snakeoil -- 26 Worms -- 27 Smoking and nicotine - poison for Crohn's, potion for colitis? -- 28 Heparin -- 29 Leukocytapheresis: filtering out the facts -- 30 Appendectomy for ulcerative colitis - a therapeutic option?.

31 Biologic treatments in IBD -- 32 Stem cell transplantation for IBD -- 33 Complementary and alternative therapy - the way forward or a step back? -- Part 4 Common Clinical Challenges: Beyond the Text Book -- 34 Functional problems -- 35 Psychological stress: something to worry about? -- 36 Drugs to avoid -- 37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD? -- 38 Iron replacement - is it safe and effective? -- 39 Hepatitis B and C viruses - how do they affect management of IBD? -- 40 Pregnancy: what drugs can we use? -- 41 How to prevent growth failure in children -- 42 Predicting outcome in severe UC -- 43 Refractory proctitis -- 44 CMV co-infection - does it matter? -- 45 Treatment of oral Crohn's disease -- 46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease -- 47 Short bowel -- 48 Management of internal fistulae -- 49 What is indeterminate colitis? -- 50 Pouches for indeterminate colitis? -- 51 Colitis-associated cancer: what's the risk to your patients? -- 52 What to do with dysplasia, DALMs, and adenomas -- Part 5 Managing IBD Outside the Gut -- 53 Pyoderma gangrenosum -- 54 Arthritides - helping the joints without harming the gut -- 55 Prevention and treatment of osteoporosis -- 56 Sclerosing cholangitis - what to do? -- 57 Thromboembolic disease: an under-recognized complication? -- 58 Pulmonary manifestations: rare but real -- Part 6 Are You Sure it's IBD? -- 59 Intestinal infections: mimics and precipitants of relapse -- 60 Microscopic colitis -- 61 Diverticular colitis -- Part 7 The IBD Service: Time for a Rethink? -- 62 Outpatient services - do doctors still have a role? -- 63 Shared care: tactical team selection -- 64 Databases - are they worth the bother? -- Index.

Evidence-based guidance to answer more than 60 controversial clinical questions on inflammatory bowel disease Clinical Dilemmas in Inflammatory Bowel Disease is a practical handbook providing quick but detailed answers to the questions and challenges that you are faced with daily in the clinical setting. Each short chapter addresses a different topic and provides evidence-based guidance on subjects ranging from optimising current management through to special management problems and novel treatments. This book is suitable for all medical professionals involved in the care of patients with IBD: established and trainee gastroenterologists, colorectal surgeons, pathologists, radiologists, specialist nurses, pharmacists, dieticians and counsellors.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2018. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.

Powered by Koha